跳至主要内容
临床试验/NCT02351843
NCT02351843终止不适用

Efficacy and Safety of Low Amplitude Electroconvulsive Therapy

Duke University2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
2
主要终点
Change in California Verbal Learning Test-II

研究概览

简要总结

The purpose of this study is to demonstrate the clinical feasibility of low amplitude electroconvulsive therapy (ECT) to reduce, and possibly eliminate the side effects of ECT by lowering the strength of the ECT stimulus from the conventional 800 mA to 500 mA. Low amplitude ECT could potentially reduce the risks associated with ECT while preserving its unparalleled efficacy. This novel development would remove key obstacles to allow for the wider adoption of ECT as a safe and effective therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Device Feasibility
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects, age 18-70
  • DSM-IV-TR diagnosis of major depressive episode in unipolar or bipolar disorder, confirmed by the MINI-PLUS
  • MMSE total score > 26
  • Referred for ECT
  • Competent to provide informed consent
  • Able to read or comprehend English

排除标准

  • Lifetime history of schizophrenia, schizoaffective disorder, mental retardation
  • Current neurostimulation treatment (e.g., ECT, magnetic seizure therapy, transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation)
  • Current alcohol abuse or dependence within past 6 months
  • Current substance abuse or dependence within past 6 months
  • History of central nervous system (CNS) disease
  • Current diagnosis of dementia or delirium
  • MoCA total score < 26
  • Current visual, auditory, or motor impairment that compromises ability to complete evaluations
  • Patients with intracranial implants
  • MRI contraindications: pregnancy, implanted metal, and claustrophobia

结局指标

主要结局

Change in California Verbal Learning Test-II

时间窗: Baseline and within 24 to 48 hours of each ECT session

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验